首页> 外文OA文献 >SAT0217 Early patient-reported outcomes and clinical outcomes with abt-494 in patients with active rheumatoid arthritis who are inadequate responders to methotrexate or tumor necrosis factor inhibitors: post-hoc analysis of phase 2 randomized controlled trials

【2h】

SAT0217 Early patient-reported outcomes and clinical outcomes with abt-494 in patients with active rheumatoid arthritis who are inadequate responders to methotrexate or tumor necrosis factor inhibitors: post-hoc analysis of phase 2 randomized controlled trials

机译：SAT0217 SAT0217早期患者报告的EABT-494在有活性类风湿性关节炎的患者中，对甲氨蝶呤或肿瘤坏死因子抑制剂的反应性不足的患者：H期随机对照试验的后HOC分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
V Strand; N Tundia; IH Song; S Meerwein; J Lin; N Chen; A Friedman;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials [J] . Lee Young Ho, Bae Sang-Cheol International journal of rheumatic diseases . 2016,第11期

机译：Tocilizumab，rituximab，abatacept和tofacitinib在对肿瘤坏死因子抑制剂反应不足的活动性类风湿关节炎患者中的比较疗效和安全性：一项随机对照试验的贝叶斯网络荟萃分析
2. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta‐analysis of randomized controlled trials [J] . Lee Young Ho, Bae Sang‐Cheol International journal of rheumatic diseases . 2016,第Suppla2期

机译：对患者的幼稚关节炎患者的对比疗效和安全性与肿瘤坏死因子抑制剂不充分应对肿瘤坏死因子抑制剂：随机对照试验的贝叶斯网络荟萃分析
3. Original article: Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond [J] . Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, RMD Open . 2019,第1期

机译：原始文章：托法替尼对活动性银屑病关节炎患者报告的结局的影响，并且在III期随机对照试验中对肿瘤坏死因子抑制剂的反应不足：OPAL Beyond
4. Poster: Classifying primary outcomes in rheumatoid arthritis: Knowledge discovery from clinical trial metadata [C] . Yuanyuan Feng, Janeja Vandana P., Yesha Yelena, IEEE International Conference on Computational Advances in Bio and Medical Sciences . 2015

机译：海报：对类风湿关节炎的主要结局进行分类：从临床试验元数据中发现知识
5. An Evaluation of Hypertension Control in the US Population and Patient-Reported Outcomes in a Clinical Trial of Heart Failure. [D] . Dinkler, John Michael. 2016

机译：在美国人群中进行的高血压控制评估和心力衰竭临床试验中患者报告的结果。
6. Original article: Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III randomised controlled trial: OPAL Beyond [O] . Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, 2019

机译：原始文章：托法替尼对活动性银屑病关节炎患者报告的结局的影响并且在III期随机对照试验中对肿瘤坏死因子抑制剂的反应不足：OPAL Beyond
7. Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial [O] . Vibeke Strand, Mark Kosinski, Chieh-I Chen, 2016

机译：Sarilumab联合甲氨蝶呤改善了活动性类风湿关节炎患者对甲氨蝶呤反应不足的患者报告的结果：一项III期试验的结果

SAT0217 Early patient-reported outcomes and clinical outcomes with abt-494 in patients with active rheumatoid arthritis who are inadequate responders to methotrexate or tumor necrosis factor inhibitors: post-hoc analysis of phase 2 randomized controlled trials

著录项

相似文献

相关主题

期刊订阅